Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above

Name: Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above
License: Public Domain

MAXVAX Biotechnology Limited Liability Company

ClinicalTrials.gov · Datasets · License: Public Domain

respiratory syncytial virus (rsv)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 256948
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.